Full Press Release Details
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Oct. 17, 2023 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that the company will present two poster presentations at the European Society of Medical Oncology (ESMO) Congress 2023 taking place October 20-24, 2023, in Madrid, Spain. The presentations will highlight the initial Phase 1b clinical data for ORIC-114 in EGFR/HER2 exon 20 mutated cancers and new preclinical data for ORIC-114 demonstrating activity against additional atypical mutations in EGFR.
In conjunction with the ESMO presentations, ORIC will host a conference call and webcast on Saturday, October 21, 2023, at 9:00 a.m. ET. Management will be joined by Dr. Alexander Spira, Clinical Director, NEXT Oncology-Virginia, who will share his perspective on the initial data from the Phase 1b study and the potential of ORIC-114 to treat EGFR/HER2 exon 20 mutated cancers.
Details of the ESMO poster presentations are as follows:
| Title: | A Global Phase 1b Study of ORIC-114, a Highly Selective, Brain Penetrant EGFR and HER2 Inhibitor, in Patients with Advanced Solid Tumors Harboring EGFR Exon 20 or HER2 Alterations |
| Poster #: | 1333P |
| Poster Session: | NSCLC, metastatic |
| Date & Time: | Monday, October 23, 2023, at 9:00 a.m. CEST |
| Title: | Preclinical Activity of ORIC-114, a Highly Selective, Brain Penetrant, |
| Irreversible Kinase Inhibitor, Against Atypical Mutations in EGFR | |
| Poster #: | 1345P |
| Poster Session: | NSCLC, metastatic |
| Date & Time: | Monday, October 23, 2023, at 9:00 a.m. CEST |
Full abstracts are available for public viewing via the ESMO website. ePosters will be available Saturday, October 21, 2023, at 9:00 a.m. CEST.
Conference Call and Webcast Details
To join the conference call via phone and participate in the live Q&A session, please pre-register online here to receive a telephone number and unique passcode required to enter the call. A live webcast and audio archive of the conference call will be available through the investor section of the company’s website at www.oricpharma.com. The webcast will be available for replay for 90 days following the presentation.
About ORIC Pharmaceuticals, Inc.
Dominic Piscitelli, Chief Financial Officer